Literature DB >> 22649023

Clinical outcome of central conventional chondrosarcoma.

Andrea Angelini1, Giovanni Guerra, Andreas F Mavrogenis, Elisa Pala, Piero Picci, Pietro Ruggieri.   

Abstract

INTRODUCTION: Aim of this study was to analyze (1) survival, local recurrence (LR), and metastasis rates between the three histological tumor grades; (2) whether type of treatment and tumor site influenced prognosis for each histologic grade.
METHODS: We retrospectively studied 296 patients with central conventional chondrosarcomas (CS) (87 grade 1, 162 grade 2, and 47 grade 3). The femur was the most common site (91 cases), followed by the pelvis (82) and other less frequent sites. Type of surgery was related with histologic grade. Margins were wide in 222 cases, marginal in 23, and intralesional in 51 cases.
RESULTS: At a mean of 7 years, 201 patients remained continuously NED, 33 were NED after treatment of relapse, 15 were AWD, 35 were died of disease, and 12 of other causes. Survival was 92% at 5 years and 84% at 10 years, significantly influenced by histological grading. In grade 3 CS, two factors influenced survival: type of surgery (resection vs. amputation, P = 0.051) and site (P = 0.039). The two significant factors lost their significance at multivariate analysis.
CONCLUSION: Central conventional CS with low/intermediate grade has a good prognosis, while high-grade tumors have poor outcome. Tumor relapses are strictly related with histologic grade.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22649023     DOI: 10.1002/jso.23173

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  54 in total

Review 1.  Genetic alterations in chondrosarcomas - keys to targeted therapies?

Authors:  Andre M Samuel; Jose Costa; Dieter M Lindskog
Journal:  Cell Oncol (Dordr)       Date:  2014-01-24       Impact factor: 6.730

2.  Chondrosarcoma of the tibial head during pregnancy: a challenging diagnosis.

Authors:  Philip P Roessler; Jan Schmitt; Susanne Fuchs-Winkelmann; Turgay Efe
Journal:  BMJ Case Rep       Date:  2014-06-30

3.  Vaginal delivery after hemipelvectomy and pelvic radiotherapy for chondrosarcoma.

Authors:  J L Browne; M A Oudijk; H R Holtslag; H W R Schreuder
Journal:  BMJ Case Rep       Date:  2014-09-25

4.  Description of the immune microenvironment of chondrosarcoma and contribution to progression.

Authors:  François A Simard; Iseulys Richert; Alexandra Vandermoeten; Anne-Valérie Decouvelaere; Jean-Philippe Michot; Christophe Caux; Jean-Yves Blay; Aurélie Dutour
Journal:  Oncoimmunology       Date:  2016-12-07       Impact factor: 8.110

5.  Surgical management of pelvic bone sarcoma with internal hemipelvectomy: Oncologic and Functional outcomes.

Authors:  Abhijeet Ashok Salunke; Jaymin Shah; Vikas Warikoo; Amit Chakraborty; Harshwardhan Sahijwani; Mohit Sharma; Rohit Jha; Avdhoot Dhange; Subodh Pathak; Jyotindra Pandit; Manish Pruthi; Shashank Pandya; Abhishek Jain
Journal:  J Clin Orthop Trauma       Date:  2017-05-06

6.  Intralesional treatment versus wide resection for central low-grade chondrosarcoma of the long bones.

Authors:  Edwin F Dierselhuis; Krista A Goulding; Martin Stevens; Paul C Jutte
Journal:  Cochrane Database Syst Rev       Date:  2019-03-07

7.  Three-dimension-printed custom-made prosthetic reconstructions: from revision surgery to oncologic reconstructions.

Authors:  Andrea Angelini; Giulia Trovarelli; Antonio Berizzi; Elisa Pala; Anna Breda; Pietro Ruggieri
Journal:  Int Orthop       Date:  2018-11-22       Impact factor: 3.075

8.  Risk factors for metastasis at presentation with conventional chondrosarcoma: a population-based study.

Authors:  Kehan Song; Xiao Shi; Xin Liang; Hongli Wang; Fei Zou; Feizhou Lu; Xiaosheng Ma; Jianyuan Jiang
Journal:  Int Orthop       Date:  2018-04-21       Impact factor: 3.075

9.  Functional and oncological outcome after surgical resection of the scapula and clavicle for primary chondrosarcoma.

Authors:  S P F T Nota; M J A M Russchen; K A Raskin; H J Mankin; F J Hornicek; J H Schwab
Journal:  Musculoskelet Surg       Date:  2016-11-29

10.  Can Machine-learning Techniques Be Used for 5-year Survival Prediction of Patients With Chondrosarcoma?

Authors:  Quirina C B S Thio; Aditya V Karhade; Paul T Ogink; Kevin A Raskin; Karen De Amorim Bernstein; Santiago A Lozano Calderon; Joseph H Schwab
Journal:  Clin Orthop Relat Res       Date:  2018-10       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.